ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors With Losses of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
[ad_1] NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.